Stifel Financial
BPMC

Stifel Financial’s Blueprint Medicines BPMC Stock Holding History

Stifel Financial’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,737
Closed -$1.17M – 3292
2022
Q3 		$1.17M Sell
17,737
-496
-3% -$31.9K ﹤0.01% 1858
2022
Q2 		$921K Sell
18,233
-1,657
-8% -$97.1K ﹤0.01% 2061
2022
Q1 		$1.27M Sell
19,890
-198
-1% -$14.2K ﹤0.01% 1939
2021
Q4 		$2.15M Sell
20,088
-551
-3% -$57.6K ﹤0.01% 1567
2021
Q3 		$2.12M Buy
20,639
+17,348
+527% +$1.62M ﹤0.01% 1537
2021
Q2 		$289K Buy
3,291
+841
+34% +$77.1K ﹤0.01% 2919
2021
Q1 		$238K Sell
2,450
-12
-0.5% -$1.2K ﹤0.01% 2923
2020
Q4 		$276K Sell
2,462
-788
-24% -$83K ﹤0.01% 2644
2020
Q3 		$301K Sell
3,250
-501
-13% -$38.6K ﹤0.01% 2400
2020
Q2 		$293K Buy
+3,751
New +$254K ﹤0.01% 2382
2020
Q1 		– Sell
-3,425
Closed -$275K – 2838
2019
Q4 		$275K Buy
+3,425
New +$256K ﹤0.01% 2581
2019
Q3 		– Sell
-10,415
Closed -$983K – 2868
2019
Q2 		$983K Buy
+10,415
New +$860K ﹤0.01% 1809

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Stifel Financial's BPMC Position: Q4 2022 in Review

Stifel Financial sold out of Blueprint Medicines (BPMC) in Q4 2022, closing a stake of 17,737 shares — an estimated $1.17M sold.

Stifel Financial first reported a position in BPMC in Q2 2019 and held it in 12 quarters. The position peaked at $2.15M in Q4 2021. 223 funds tracked by Wall St. Rank hold BPMC as of Q4 2022.

  • Stifel Financial reported no remaining Blueprint Medicines position as of Q4 2022 after selling out during the quarter.
  • Stifel Financial sold 17,737 Blueprint Medicines shares in Q4 2022, an estimated $1.17M.
  • Stifel Financial first reported a position in Blueprint Medicines in Q2 2019 and held it in 12 quarters.
  • Stifel Financial's Blueprint Medicines position peaked at $2.15M in Q4 2021.
  • 223 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2022.

Based on Stifel Financial's 13F filing for Q4 2022, filed 13 Feb 2023.